Algea Therapies, a division of Globus Medical Inc. (NYSE: GMED), committed to finding innovative, minimally invasive solutions that treat pain and restore quality of life, today announced the launch of the SHIELD?
BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading spinal implant manufacturer, today announced the launch of FORTIFY� I, an expandable corpectomy spacer with integrated screws for further stability in addition to supplemental fixation.
AUDUBON, Pa.--(BUSINESS WIRE)-- Globus Medical, Inc. (NYS: GMED) , a leading spinal implant manufacturer, today announced that Richard Baron, Senior Vice President and Chief Financial Officer, will participate at two upcoming investor events in May: ...
Globus Medical has a 1-year low of $10.26 and a 1-year high of $19.93. The stock's 50-day moving average is currently $15.22. The company has a market cap of $1.423 billion and a price-to-earnings ratio of 18.85.
Globus Medical (NASDAQ: GMED) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.01.